Weber Health Solutions LLC is Weber’s company in the United States, based in Dover, Delaware. It is our gateway to the most innovative, competitive and regulated healthcare market in the world and, above all, our point of contact with the global headquarters of pharmaceutical and medtech companies and with the international consultancies we have worked with for more than a decade.
From Weber USA we connect two worlds: the global teams that design the value strategy for an innovation, and the European and Latin American health systems where that innovation has to prove it.
A global headquarters has the value dossier, the economic model and the value story for its innovation. What it does not always have is the answer to what happens when that strategy reaches a specific system: what evidence does the Spanish, Portuguese or Mexican assessor ask for? Which comparator, which costs, which perspective? What social value does each country recognise, and how is it negotiated in each one?
And the other way round: what can a global team learn from how public European systems assess, fund and purchase? What cost and clinical-practice data does a global model need to be credible in each country?
At Weber USA we believe those questions are best answered by a partner who understands both the global logic and the local reality.
1.
We work with HEOR, market access and public affairs teams at headquarters, in English and at their pace, as an extension of their own team: global access plans, training, dossiers and models.
2.
We adapt global value dossiers, cost-effectiveness and budget-impact models and pricing and reimbursement tools to the health systems of Spain, Portugal, Europe and Latin America, with our local teams.
3.
We are a regular supplier of cost and clinical-practice data for global models in the United States, the five major European markets, Poland, Russia and Vietnam, for international consultancies and companies.
4.
Burden-of-disease studies, social value, multi-criteria decision analysis and public-affairs strategies that a headquarters can roll out in several countries at once.
5.
Dover, Madrid, Lisbon and Mexico City work as a squad: a global project is designed with headquarters and delivered by the people who know each market.
– Why clients choose us –
We combine robust methodologies, systems analysis, data, people and lateral thinking to understand every challenge from every angle, ask questions you probably have never stopped to consider, and build deeper, more useful and actionable solutions.
Because what sets us apart is not only what we know.
It is how we think.
Our own framework for valuing innovation beyond classic assessment: productivity, caregivers, equity, social return. For a global headquarters, it is a way to build a value story that works across very different systems.
Health economics, market access, real-world evidence, data, foresight and communication working on your challenge at the same time, with people from the United States, Spain, Portugal and Mexico on the same team.
Cost databases for the United States, EU5, Poland, Russia and Vietnam, models, simulators and data platforms developed by Weber Data & Technology, ready to feed a global model or adapt it to each country.
– track record –
Since 2013 we have worked with the headquarters of pharmaceutical and medtech companies and with international consultancies based in the United States and the United Kingdom. Some examples:
— our promise —
— our value —
Our value is demonstrated by our ability to turn knowledge into decisions, decisions into action and action into impact.
— PEOPLE ARE THE KEY —
Country Manager, Weber USA. Degree in Business Administration, Marketing and Finance; MBA in International Management.
Brings a disruptive perspective to every project we carry out across the different areas.
As department director and scientific lead, she defines the data strategy associated with each project to ensure that the evidence we generate is truly distinctive.
As scientific director, he ensures sound methodological design and results aligned with HTA processes and innovation access policies.
Leads the development of strategies, studies and tools to demonstrate the clinical, economic and social value of treatments, technologies and healthcare innovations.
This work helps facilitate access, funding, adoption and positioning within the healthcare system.
Leads the development of economic evaluation models and studies to measure the cost, efficiency and budget impact of treatments, technologies and healthcare interventions.
The work of this area enables alternatives to be compared, the value of innovation to be quantified and evidence to be generated to support better funding, prioritisation and healthcare resource-allocation decisions.
Leads the analysis of health outcomes using real-world evidence (RWE) to understand how treatments and healthcare interventions perform in routine clinical practice.
This work enables effectiveness, quality of life and patient experience to be measured, generating evidence to demonstrate the value of innovation and support access, funding and healthcare management decisions.
Analyses health policies, regulatory frameworks, trends, stakeholders and decision scenarios to generate strategic intelligence.
The aim is to help organisations and institutions understand the context, anticipate change and guide complex healthcare decisions.
Connects Weber with patients, associations, institutions, public administrations and other key stakeholders across the healthcare ecosystem.
This work drives participation, public affairs, institutional relations and the inclusion of the patient voice in decision-making processes.
This department turns the knowledge generated by Weber into content, publications, training activities and communication materials.
In this way, we facilitate the transfer of evidence to professionals, patients, institutions and society, making knowledge more accessible, useful and shareable.
Develops strategic foresight projects to analyse possible futures, identify critical variables, interpret signals of change and design anticipatory strategies.
Our unique approach and methodology help public and private organisations make better decisions in uncertain contexts.
Weber Health Solutions LLC
8 The Green, Suite A,
Dover, DE 19901,
USA
eduardo.magallanes@weber.org.es
